2009Zhongguo aizheng zazhiRequires access

Effect of pre-emptive analgesia with flurbiprofen axetil and tramadol on lymphocyte counts in patients of breast cancer

Wei Chen

Open publisher page 0 citations

Abstract

Background and purpose:It is widely accepted that pre-emptive analgesia has great effects on alleviation of postoperative pain, while pre-emptive analgesic effect on immune system has not been well studied. In this study, we evaluated the effect of pre-emptive analgesia of flurbiprofen axetil and tramadol on lymphocyte counts in patients of breast cancer. Methods:In this prospective randomized, double-blind, placebo-controlled study, eighty patients were randomly assigned to one of four groups (n=20).Fifteen min before tracheal intubation,the FA group (group A) received iv flurbiprofen axetil 1 mg/kg, the tramadol group (group B) received iv tramadol 1 mg/kg, the control group (group C) received iv saline 20 ml, the combination group (group D) received iv flurbiprofen axetil 0.5 mg/kg and tramadol 0.5 mg/kg. At the end of surgery, the FA group (group A) patients received iv flurbiprofen axetil 0.5 mg/kg, the tramadol group (group B) patients received iv tramadol 0.5 mg/kg, the control group (group C) patients received iv saline 20 ml, the combination group (group D) patients received iv flurbiprofen axetil 0.25 mg/kg and tramadol 0.25 mg/ kg. Peripheral venous blood samples were collected 30 min before tracheal intubation(T0), 30 min postoperatively(T0.5), 4 hrs postoperatively(T4),24 hrs postoperatively(T24) for the determination of CD3+, CD4+, CD8+ and lymphocyte and measured by flow cytometry. Results:The characteristics of the patients in four groups were similar in terms ofage, body mass index (BMI), anesthesia time and operation time. There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes at T0 among four groups. The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes increased at T24 as compared to those at T4 but decreased at T24 than those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 , T24 as compared to those at T0 of group A and D (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group B (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group B (P0.05). There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes between T0.5 and T24 of group B. The CD3+, CD4+, CD8+ and lymphocytes of group D were higher than those of group C at T0.5 and T4 (P0.05). Conclusion:Pre-emptive analgesia of flurbiprofen axetil and tramadol has a positive effect on alleviating immunosuppression induced by surgery and anesthesia, thus it also protects the immune system in patients with breast cancer.

About this research paper

What this paper is about

Background and purpose:It is widely accepted that pre-emptive analgesia has great effects on alleviation of postoperative pain, while pre-emptive analgesic effect on immune system has not been well studied. In this study, we evaluated the effect of pre-emptive analgesia of flurbiprofen axetil and tramadol on lymphocyte counts in patients of breast cancer. Methods:In this prospective randomized, double-blind, placebo-controlled study, eighty patients were randomly assigned to one of four groups (n=20).Fifteen min before tracheal intubation,the FA group (group A) received iv flurbiprofen axetil 1 mg/kg, the tramadol group (group B) received iv tramadol 1 mg/kg, the control group (group C) received iv saline 20 ml, the combination group (group D) received iv flurbiprofen axetil 0.5 mg/kg and tramadol 0.5 mg/kg. At the end of surgery, the FA group (group A) patients received iv flurbiprofen axetil 0.5 mg/kg, the tramadol group (group B) patients received iv tramadol 0.5 mg/kg, the control group (group C) patients received iv saline 20 ml, the combination group (group D) patients received iv flurbiprofen axetil 0.25 mg/kg and tramadol 0.25 mg/ kg. Peripheral venous blood samples were collected 30 min before tracheal intubation(T0), 30 min postoperatively(T0.5), 4 hrs postoperatively(T4),24 hrs postoperatively(T24) for the determination of CD3+, CD4+, CD8+ and lymphocyte and measured by flow cytometry. Results:The characteristics of the patients in four groups were similar in terms ofage, body mass index (BMI), anesthesia time and operation time. There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes at T0 among four groups. The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes increased at T24 as compared to those at T4 but decreased at T24 than those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 , T24 as compared to those at T0 of group A and D (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group B (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group B (P0.05). There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes between T0.5 and T24 of group B. The CD3+, CD4+, CD8+ and lymphocytes of group D were higher than those of group C at T0.5 and T4 (P0.05). Conclusion:Pre-emptive analgesia of flurbiprofen axetil and tramadol has a positive effect on alleviating immunosuppression induced by surgery and anesthesia, thus it also protects the immune system in patients with breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background and purpose:It is widely accepted that pre-emptive analgesia has great effects on alleviation of postoperative pain, while pre-emptive analgesic effect on immune system has not been well studied. In this study, we evaluated the effect of pre-emptive analgesia of flurbiprofen axetil and tramadol on lymphocyte counts in patients of breast cancer. Methods:In this prospective randomized, double-blind, placebo-controlled study, eighty patients were randomly assigned to one of four groups (n=20).Fifteen min before tracheal intubation,the FA group (group A) received iv flurbiprofen axetil 1 mg/kg, the tramadol group (group B) received iv tramadol 1 mg/kg, the control group (group C) received iv saline 20 ml, the combination group (group D) received iv flurbiprofen axetil 0.5 mg/kg and tramadol 0.5 mg/kg. At the end of surgery, the FA group (group A) patients received iv flurbiprofen axetil 0.5 mg/kg, the tramadol group (group B) patients received iv tramadol 0.5 mg/kg, the control group (group C) patients received iv saline 20 ml, the combination group (group D) patients received iv flurbiprofen axetil 0.25 mg/kg and tramadol 0.25 mg/ kg. Peripheral venous blood samples were collected 30 min before tracheal intubation(T0), 30 min postoperatively(T0.5), 4 hrs postoperatively(T4),24 hrs postoperatively(T24) for the determination of CD3+, CD4+, CD8+ and lymphocyte and measured by flow cytometry. Results:The characteristics of the patients in four groups were similar in terms ofage, body mass index (BMI), anesthesia time and operation time. There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes at T0 among four groups. The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes increased at T24 as compared to those at T4 but decreased at T24 than those at T0.5 of group C (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 , T24 as compared to those at T0 of group A and D (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T0.5, T4 , T24 as compared to those at T0 of group B (P0.05). The CD3+, CD4+, CD8+ and lymphocytes decreased at T4 as compared to those at T0.5 of group B (P0.05). There were no significant differences in CD3+, CD4+, CD8+ and lymphocytes between T0.5 and T24 of group B. The CD3+, CD4+, CD8+ and lymphocytes of group D were higher than those of group C at T0.5 and T4 (P0.05). Conclusion:Pre-emptive analgesia of flurbiprofen axetil and tramadol has a positive effect on alleviating immunosuppression induced by surgery and anesthesia, thus it also protects the immune system in patients with breast cancer.

Key concepts: Tramadol, Medicine, Anesthesia, Flurbiprofen, Saline, Analgesic, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of pre-emptive analgesia with flurbiprofen axetil and tramadol on lymphocyte counts in patients of breast cancer — Research Paper | ScholarLens